Ironshore Pharmaceuticals and Development, Inc
7 clinical trials · Sponsor
◉ Watch Ironshore Pharmaceuticals and Development, Inc
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years With ADHD (NCT06431256) | Ironshore Pharmaceuticals and Development, Inc | 2024-09-13 |
Track Ironshore Pharmaceuticals and Development, Inc automatically
Every clearance here is in the API, with alerts when new ones post.